A carregar...
Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
Many patients with chronic kidney disease (CKD) receive anticoagulation or antiplatelet therapy due to atrial fibrillation, coronary artery disease, thromboembolic disease, or peripheral artery disease. The treatment usually includes vitamin K antagonists (VKAs) and/or platelet aggregation inhibitor...
Na minha lista:
| Publicado no: | Int J Nephrol Renovasc Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473496/ https://ncbi.nlm.nih.gov/pubmed/28652799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S105771 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|